Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.
Heinz
Carsten
C
Merz
Hartmut
H
Nieschalk
Matthias
M
Mueller-Miny
Heribert
H
Koch
Peter
P
Heiligenhaus
Arnd
A
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000188:drug therapy*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab